Chargement en cours...
Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial
BACKGROUND: Although the majority of Class III congestive heart failure (HF) patients treated with cardiac resynchronization therapy (CRT) show a clinical benefit, up to 40% of patients do not respond to CRT. This paper reports the design of the MultiPoint Pacing (MPP) trial, a prospective, randomiz...
Enregistré dans:
| Publié dans: | Ann Noninvasive Electrocardiol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931776/ https://ncbi.nlm.nih.gov/pubmed/28517367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12448 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|